...
首页> 外文期刊>Diagnostic microbiology and infectious disease >Antimicrobial Susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa Isolates from United States Medical Centers Stratified by Infection Type: Results from the International Network for Optimal Resistance Monitoring (INFORM) Surveillance Program, 2015–2016
【24h】

Antimicrobial Susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa Isolates from United States Medical Centers Stratified by Infection Type: Results from the International Network for Optimal Resistance Monitoring (INFORM) Surveillance Program, 2015–2016

机译:Enterobacteriaceae和假单胞菌铜绿假单胞菌的抗菌易感性来自受感染类型分层的美国医疗中心:2015-2016的国际最优阻力监测(通知)监控计划的结果

获取原文
获取原文并翻译 | 示例
           

摘要

A total of 18,656Enterobacteriaceaeand 4,175Pseudomonas aeruginosawere consecutively collected from 85 US hospitals and tested for susceptibility by broth microdilution methods in a central monitoring laboratory (JMI Laboratories). The antimicrobial susceptibility and frequency of key resistance phenotypes were assessed and stratified by infection type as follows: bloodstream (BSI; 3,434 isolates; 15.0%), pneumonia (6,439; 28.2%), skin and skin structure (SSSI; 4,134; 18.1%), intra-abdominal (IAI; 951; 4.2%), and urinary tract (UTI; 7,873; 34.5%). Ceftazidime-avibactam was active against 99.9% to 100.0% ofEnterobacteriaceaeand 97.0% (pneumonia) to 99.4% (UTI) ofP. aeruginosaisolates. Susceptibility rates were consistently lower for β-lactams, such as ceftazidime (82.3% vs. 87.1–90.8%), piperacillin-tazobactam (87.5% vs. 90.2–95.6%), and meropenem (96.8% vs. 98.4–99.4%) amongEnterobacteriaceaefrom pneumonia compared to other infection types. Susceptibility to gentamicin was also generally lower among isolates from pneumonia, whereas susceptibility to levofloxacin and colistin were lowest among BSI and SSSI isolates, respectively. The occurrence of multidrug-resistance (MDR; 8.2% overall), extensively drug-resistance (XDR; 1.1% overall), and carbapenem-resistantEnterobacteriaceae(CRE; 1.3% overall) phenotypes were markedly higher among isolates from patients with pneumonia compared to other infection types. AmongP. aeruginosa, susceptibility rates for ceftazidime, piperacillin-tazobactam, and gentamicin were lowest among isolates from pneumonia, whereas susceptibility to meropenem was similar among isolates from BSI, pneumonia, and IAI (77.3–77.9%), and susceptibility to levofloxacin was markedly lower among UTI isolates (67.1%). The frequencies ofP. aeruginosaisolates with MDR and XDR phenotypes were highest among isolates from patients with pneumonia.
机译:总共18,656个,18,656个蛋白杆菌,4,175pseudomonas Aruginosawere从85家美国医院收集,并通过肉汤微量稀释方法进行了敏感性,在中央监测实验室(JMI实验室)。通过感染类型评估和分层的抗微生物敏感性和频率的关键阻力表型如下:血液(BSI; 3,434分离物; 15.0%),肺炎(6,439; 28.2%),皮肤和皮肤结构(SSSI; 4,134; 18.1%) ,腹内(IAI; 951; 4.2%)和泌尿道(UTI; 7,873; 34.5%)。 Ceftazidime-Avibactam对99.9%至100.0%的EterobacteriaceAnd 97.0%(肺炎)至99.4%(UTI)的59.4%(UTI)。铜绿假单胞菌。 β-内酰胺的易感性率持续降低,例如头孢唑胺(82.3%与87.1-90.8%),Piperacillin-tazobactam(87.5%与90.2-95.6%),梅洛尼姆(96.8%vs.98.4-99.4%)与其他感染类型相比,肺炎杆菌血管基因杆菌。对肺炎的分离物中,庆大霉素的易感性通常也较低,而对BSI和SSSI分离株的对左氧氟沙星和Colistin的易感性也是最低的。多药抗性(MDR; 8.2%总体),广泛的耐药性(总体XDR; 1.1%),以及肺炎患者与其他肺炎的患者的分离物中显着高出了肺癌抗性的抗菌剂(CRE; 1.3%总体)表型。感染类型。其中。铜硝基菌,哌啶素 - 塔沙漠酰胺和庆大霉素的易感性率在肺炎的分离物中最低,而对梅洛涅姆的敏感性在BSI,肺炎和IAI的分离物中相似,并且对左氧氟沙星的易感性显着降低UTI分离物(67.1%)。频率OFP。肺炎患者的分离物中铜绿假单胞菌和XDR表型在肺炎患者中是最高的。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号